Literature DB >> 23102645

Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease.

David Walsh1, Joanna McCarthy, Caitriona O'Driscoll, Silvia Melgar.   

Abstract

Pattern recognition receptors (PRRs) are a family of germline encoded receptors responsible for the detection of "pathogen associated molecular patterns" (PAMPs) or host derived "damage associated molecular patterns" (DAMPs) which induce innate immune signalling to generate a pro-inflammatory profile within the host. Four main classes of PRRs are recognised, Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-like receptors (RLRs) and C-type lectin receptors (CLRs). Abnormal activation of PRRs has been implicated in various autoimmune and inflammatory conditions including rheumatoid arthritis and asthma. Recent growing evidence has implicated these PRRs as contributory elements to the pathogenesis of inflammatory bowel disease (IBD) and colitis-associated cancer (CAC). Here, the current literature which implicates PRRs in IBD and CAC is comprehensively reviewed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102645     DOI: 10.1016/j.cytogfr.2012.09.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  44 in total

Review 1.  Contributions of the intestinal microbiome in lung immunity.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Eur J Immunol       Date:  2017-08-31       Impact factor: 5.532

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

3.  The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.

Authors:  Tere M Williams; Rachel A Leeth; Daniel E Rothschild; Sheryl L Coutermarsh-Ott; Dylan K McDaniel; Alysha E Simmons; Bettina Heid; Thomas E Cecere; Irving C Allen
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

4.  TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.

Authors:  Hongyu Zhang; Tianfeng Zhu; Wenwen Liu; Xin Qu; Ye Chen; Ping Ren; Ziying Wang; Xinbing Wei; Yan Zhang; Fan Yi
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

5.  Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.

Authors:  Angela Isabel Cabrera-García; Jan S Suchodolski; Jörg M Steiner; Romy M Heilmann
Journal:  J Vet Diagn Invest       Date:  2020-07-27       Impact factor: 1.279

6.  MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltage-dependent anion channel 1.

Authors:  Kai Guan; Zirui Zheng; Ting Song; Xiang He; Changzhi Xu; Yanhong Zhang; Shengli Ma; Ying Wang; Quanbin Xu; Ye Cao; Jia Li; Xiaoli Yang; Xiaoxing Ge; Congwen Wei; Hui Zhong
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

Review 7.  Microbial activation of gut dendritic cells and the control of mucosal immunity.

Authors:  Jennifer L Owen; Mansour Mohamadzadeh
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

Review 8.  New insights into TRP channels: Interaction with pattern recognition receptors.

Authors:  Huirong Han; Fan Yi
Journal:  Channels (Austin)       Date:  2013-12-03       Impact factor: 2.581

Review 9.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population.

Authors:  Hong-xin Zhang; Zheng-ting Wang; Xiong-xiong Lu; Yan-gui Wang; Jie Zhong; Jie Liu
Journal:  Inflamm Res       Date:  2014-10-09       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.